Position in DNLI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,211,331
+$1,071,546 QoQ
Shares Held
1,104,757
-9.4% QoQ
Ownership
0.696%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 71.3177649021459.ToString("F0")%
Shared 0.ToString("F0")%
None 28.682235097854097.ToString("F0")%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. DNLI ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,211,331 | 1,104,757 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,139,785 | 1,219,854 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $24,531,419 | 1,689,492 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $18,355,097 | 1,312,016 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $17,042,727 | 1,253,603 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,049,868 | 1,229,140 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $50,824,709 | 1,744,755 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $28,418,442 | 1,223,878 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $19,045,140 | 928,126 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $20,976,995 | 977,493 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $20,249,763 | 981,569 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $31,778,901 | 1,076,886 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,112,568 | 569,122 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,027,432 | 432,486 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $20,910,075 | 681,332 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,449,209 | 423,011 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $22,700,918 | 705,655 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $12,811,704 | 287,258 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,372,443 | 383,993 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,810,146 | 431,032 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $26,389,332 | 462,160 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $18,379,287 | 219,428 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,923,133 | 304,860 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,711,654 | 318,927 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,721,438 | 155,422 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||